Literature DB >> 23564310

Combination therapy of voriconazole and terbinafine for disseminated fusariosis: case report and literature review.

Shojiro Inano1, Masahiro Kimura, Jun Iida, Nobuyoshi Arima.   

Abstract

Fusarium spp. cause a broad spectrum of infection and are relatively resistant to most antifungal agents, leading to unfavorable prognosis, especially in immunocompromised patients. Several reports have shown synergism among amphotericin B, voriconazole (VRC), terbinafine (TRB), and other antifungal agents in vitro, but the most efficacious combination remains to be elucidated. We report the first case of disseminated Fusarium solani infection successfully treated by combination therapy of VRC and TRB accompanied by surgical resection of endocardial lesions. We also review 15 case reports of combination antifungal therapy for fusariosis and 6 case reports of Fusarium endocarditis.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23564310     DOI： 10.1007/s10156-013-0594-9

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN： 1341-321X            Impact factor:   2.211


  9 in total

Review 1.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

Review 2.  [Cutaneous infection due to Fusarium oxysporum in a female diabetic: molecular biological detection of the mold from formalin-fixed paraffin embedded tissue using sequencing of the ITS region of the rDNA].

Authors:  P Nenoff; A Bernhardt; K Tintelnot; V Kingreen; P Dücker; M Cofalka; J Schaller
Journal:  Hautarzt       Date:  2014-06       Impact factor: 0.751

3.  Fusarium Infection in a Kidney Transplant Recipient Successfully Treated with Voriconazole.

Authors:  Ahmed M Alkhunaizi; Ali M Bazzi; Ali A Rabaan; Elwaleed A Ahmed
Journal:  Case Rep Infect Dis       Date:  2018-08-07

4.  Activity of Amphotericin B Formulations and Voriconazole, Alone or in Combination, against Biofilms of Scedosporium and Fusarium spp.

Authors:  Katerina Vikelouda; Maria Simitsopoulou; Lemonia Skoura; Charalampos Antachopoulos; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2021-08-09       Impact factor: 5.191

5.  Invasive Fusariosis in the Voriconazole Era: Single-Center 13-Year Experience.

Authors:  Jessica M Stempel; Sarah P Hammond; Deanna A Sutton; Linda M Weiser; Francisco M Marty
Journal:  Open Forum Infect Dis       Date:  2015-07-04       Impact factor: 3.835

6.  Colonization of a Central Venous Catheter by the Hyaline Fungus Fusarium solani Species Complex: A Case Report and SEM Imaging.

Authors:  Alberto Colombo; Giuseppe Maccari; Terenzio Congiu; Petra Basso; Andreina Baj; Antonio Toniolo
Journal:  Case Rep Med       Date:  2013-07-02

7.  Fusarium napiforme systemic infection: case report with molecular characterization and antifungal susceptibility tests.

Authors:  Marcela de Souza; Tetsuhiro Matsuzawa; Luzia Lyra; Ariane Fidelis Busso-Lopes; Tohru Gonoi; Angélica Zaninele Schreiber; Katsuhiko Kamei; Maria Luiza Moretti; Plínio Trabasso
Journal:  Springerplus       Date:  2014-08-30

8.  Intracranial fusarium fungal abscess in an immunocompetent patient: case report and review of the literature.

Authors:  Asa Peterson; Martin H Pham; Brian Lee; Deborah Commins; Joseph Cadden; Steven L Giannotta; Gabriel Zada
Journal:  J Neurol Surg Rep       Date:  2014-11-12

Review 9.  Reduced Multidrug Susceptibility Profile Is a Common Feature of Opportunistic Fusarium Species: Fusarium Multi-Drug Resistant Pattern.

Authors:  Saad J Taj-Aldeen
Journal:  J Fungi (Basel)       Date:  2017-04-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.